ReviewBiomarker research2026
The cGAS-STING pathway at the crossroads of neuroimmunology: bridging innate immunity to aging and neurodegeneration.
Review in Biomarker research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mounting evidence indicates that aging and neurodegenerative diseases extensively interact with brain immune processes. Cyclic GMP-AMP synthase (cGAS) recognizes aberrant DNA to produce 2‘3’-cGAMP, which activates STING and subsequently induces the type-I interferon response and transcription of inflammatory factors, leading to neuroinflammation that accelerates various acute and chronic neurological disorders. In this review, we summarized the features of cGAS and STING, and depicted the mechanisms concerning exogenous DNA, mitochondrial DNA, nuclear DNA, and protein phase separation in activating the cGAS-STING pathway. Moreover, the multifunctional roles of the cGAS-STING pathway in aging and neurological disorders were highlighted, and the known cGAS or STING inhibitors for the therapy of neurological disorders were discussed. This review summarizes the intricate interplay between the cGAS-STING pathway and neurodegenerative diseases, underscoring its pivotal role in neurodegenerative processes and brain health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.